---
schema_version: "secwatch.filing_event.v1"
accession: "0000313143-24-000047"
form_type: "8-K/A"
ticker: "HAE"
cik: "0000313143"
company_name: "HAEMONETICS CORP"
filed_at: "2024-07-30T23:59:59+00:00"
generated_at: "2026-05-31T15:29:19.028178+00:00"
event_type: "other"
sentiment: "neutral"
materiality_score: 0.1
calibrated_materiality_score: 0.1
confidence: "high"
source: SEC EDGAR
---

# Haemonetics shareholders elect directors, approve executive pay and auditor at 2024 annual meeting

## Summary
- All 9 director nominees elected with ~47.1M–47.6M votes each; no director received less than 46.8M for.
- Advisory vote on executive compensation passed with 46.2M for, 1.46M against, 142k abstain.
- Ratification of Ernst & Young as auditor for FY ending March 29, 2025: 47.74M for, 1.05M against.
- Quorum of 48.9M shares (95.99% of outstanding) present at the July 25, 2024 meeting.
- Amendment corrects clerical error in original 8-K regarding fiscal year reference in proposal 3 description.

## SEC filing metadata
- accession: 0000313143-24-000047
- form_type: 8-K/A
- ticker: HAE
- cik: 0000313143
- company_name: HAEMONETICS CORP
- filed_at: 2024-07-30T23:59:59+00:00
- event_type: other
- sentiment: neutral
- materiality_score: 0.1
- calibrated_materiality_score: 0.1
- confidence: high
- sec_items: 5.07
- EDGAR index: https://www.sec.gov/Archives/edgar/data/313143/000031314324000047/0000313143-24-000047-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/313143/000031314324000047/hae-20240725.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000313143-24-000047
- JSON: https://secwatch.observer/filing/0000313143-24-000047.json
- Plain text: https://secwatch.observer/filing/0000313143-24-000047.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.